Luigi Portella — Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Area of research

Pulmonary and Respiratory Medicine · Oncology

Research interest

Research interests include Prostate Cancer Treatment and Research, Chemokine receptors and signaling, Cancer Immunotherapy and Biomarkers, and Renal cell carcinoma treatment.

Recent publications

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies

Journal for ImmunoTherapy of Cancer 2022cited by 62position: middledoi

CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients

Cells 2022cited by 13position: middledoi

Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY

Clinical Cancer Research 2018cited by 121position: middledoi

Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer

Journal of Clinical Oncology 2017cited by 81position: middledoi

Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer

Cancer Research 2014cited by 260position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Pulmonary and Respiratory Medicine · Oncology →